Institut Jean Paoli & Irène Calmettes;Université d'Aix-Marseille;Institut National de la Santé et de la Recherche Médicale (INSERM);Centre National de la Recherche Scientifique;Université de Bordeaux
发明人:
申请号:
EP14728205.7
公开号:
EP3003274B1
申请日:
2014.06.05
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
The present invention concerns an oligonucleotide modified by substitution at the 3′ or the 5′ end by a moiety comprising at least three saturated or unsaturated, linear or branched hydrocarbon chains comprising from 2 to 30 carbon atoms, and the use therefore as a medicament, in particular for use for treating cancer.